Back to search results

Audio-Based Therapy for Anxiety in Psoriasis

This study is exploring whether listening to specific audio can help reduce anxiety for people with psoriasis (a skin condition). We are testing two types of audio: "Music Therapy" (music with added auditory beat stimulation) and "Pink Noise." You might be able to join if you are 18 or older, have psoriasis diagnosed by a dermatologist, and have some anxiety symptoms (a GAD 2-Item Score of 1 or higher). The main goal is to see if these audio interventions can improve your anxiety symptoms, which will be measured right before and after a single 30-minute session. We plan to enroll 120 people, but the current status of the study is unclear.

Study design
This study plans to enroll 120 participants to test two different audio interventions: Music Therapy and Pink Noise.
What's involved
You would participate in a single 23-30 minute session at home, using a computer/smartphone with headphones, and complete surveys before and after.
Compensation
Not stated in the trial record.
Follow-up
Anxiety is measured from the pre-intervention survey to the post-intervention survey, approximately 30 minutes later.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07390487

The Effects of Audio-Based Therapy on Anxiety in Psoriasis

Recruiting
NAAges 18+InterventionalSupportive care
University of California, San Francisco
~120 participants
Updated 2026-07-23 on ClinicalTrials.gov
What's tested:Music TherapyPink Noise

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Anxiety: State Trait Inventory for Cognitive and Somatic Anxiety (STICSA)
Measured over From the pre-intervention survey to the post-intervention survey, approximately 30 minutes.

Conditions

Psoriasis (PsO)
Anxiety

Explore related trials

Psoriasis

Where it's being run

1 sites across 1 states
California1

Study leadership

  • Wilson Liao, MD · PRINCIPAL_INVESTIGATOR · University of California, San Francisco

Who to contact

Amélie Spangenberg, Psoriasis Clinical Research Fellow, MBBS
[email protected]
415-944-7618
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age ≥18 years
Self-reported dermatologist-diagnosed psoriasis
GAD 2-Item Score ≥1 at screening
Ability to consent and complete pre- and post-intervention surveys.
Internet access and the ability to use a computer/smartphone with headphones for a single 23-30 minute session at home.

Exclusion

Severe hearing impairment precluding headphone listening
Any condition requiring strict sound avoidance (such as seizure/epilepsy, major head trauma, severe sound-triggered migraine) that would make participation unsafe.
Other diagnoses that in the investigator's judgment preclude safe participation or interfere with anxiety or psoriasis evaluation.

What this trial measures

  • Anxiety: State Trait Inventory for Cognitive and Somatic Anxiety (STICSA)From the pre-intervention survey to the post-intervention survey, approximately 30 minutes.

    The STICSA has good reliability and validity as a measure of state and trait cognitive and somatic anxiety. In this study, the post-intervention anxiety score is subtracted from the pre-intervention anxiety score, giving a measure of anxiety reduction. Greater anxiety reduction scores would indicate a better anxiety outcome.